Resources Management Corp Gilead Sciences, Inc. Transaction History

Resources Management Corp

$741 Million
Q3 2024

A detailed history of Resources Management Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Resources Management Corp holds 22,956 shares of GILD stock, worth $2.03 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

22,956

Previous 23,631 2.86%

Holding current value

$2.03 Million

Previous $1.62 Million 18.75%

% of portfolio

0.26%

Previous 0.24%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$66.59 - $83.99 $44,948 - $56,693	-675 Reduced 2.86%	22,956 $1.93 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $110,891 - $127,977	-1,756 Reduced 6.92%	23,631 $1.62 Million
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $27,128 - $33,082	-379 Reduced 1.47%	25,387 $1.86 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $1.88 Million - $2.13 Million	25,685 Added 31709.88%	25,766 $2.09 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $2 Million - $2.26 Million	-27,250 Reduced 99.7%	81 $2.09 Million
Q3 2023 Nov 16, 2023	BUY	$73.94 - $80.67 $28,023 - $30,573	379 Added 1.41%	27,331 $2.05 Million
Q2 2023 Aug 16, 2023	BUY	$76.01 - $86.7 $2.04 Million - $2.32 Million	26,815 Added 19572.99%	26,952 $2.08 Million
Q1 2023 May 11, 2023	SELL	$77.31 - $88.08 $2.18 Million - $2.49 Million	-28,220 Reduced 99.52%	137 $2,000
Q4 2022 Feb 08, 2023	SELL	$62.32 - $89.47 $4,985 - $7,157	-80 Reduced 0.28%	28,357 $2.43 Million
Q3 2022 Nov 15, 2022	SELL	$59.54 - $68.01 $316,752 - $361,813	-5,320 Reduced 15.76%	28,437 $1.75 Million
Q2 2022 Aug 10, 2022	SELL	$57.72 - $65.01 $74,054 - $83,407	-1,283 Reduced 3.66%	33,757 $2.09 Million
Q1 2022 May 20, 2022	SELL	$57.92 - $72.58 $60,236 - $75,483	-1,040 Reduced 2.88%	35,040 $2.08 Million
Q4 2021 Feb 04, 2022	SELL	$64.88 - $73.64 $83,046 - $94,259	-1,280 Reduced 3.43%	36,080 $2.62 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $126,580 - $136,566	-1,870 Reduced 4.77%	37,360 $2.61 Million
Q2 2021 Aug 10, 2021	SELL	$63.47 - $69.35 $61,312 - $66,992	-966 Reduced 2.4%	39,230 $2.7 Million
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $449,100 - $512,423	-7,485 Reduced 15.7%	40,196 $2.6 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $28,551 - $32,533	-504 Reduced 1.05%	47,681 $2.78 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $16,767 - $21,081	-270 Reduced 0.56%	48,185 $3.05 Million
Q2 2020 Aug 11, 2020	SELL	$72.34 - $84.0 $3,617 - $4,200	-50 Reduced 0.1%	48,455 $3.73 Million
Q1 2020 May 04, 2020	SELL	$62.63 - $80.22 $646,717 - $828,351	-10,326 Reduced 17.55%	48,505 $3.63 Million
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $1,540 - $1,694	-25 Reduced 0.04%	58,831 $3.82 Million
Q3 2019 Dec 04, 2019	BUY	$62.51 - $69.0 $192,155 - $212,106	3,074 Added 5.51%	58,856 $3.73 Million
Q4 2018 Feb 21, 2019	SELL	$60.54 - $79.0 $124,349 - $162,266	-2,054 Reduced 3.55%	55,782 $3.49 Million
Q3 2018 Nov 15, 2018	BUY	$71.28 - $78.92 $4.12 Million - $4.56 Million	57,836 New	57,836 $4.47 Million

Others Institutions Holding GILD

# of Institutions

1,925

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Resources Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Resources Management Corp with notifications on news.

Account

Resources Management Corp Gilead Sciences, Inc. Transaction History